Women's Health Market Research Reports & Industry Analysis
Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.
Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.
Women's Health Industry Research & Market Reports
-
Breast Cancer Liquid Biopsy
... 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Liquid Biopsy Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.4% CAGR and reach US$819.3 Million ... Read More
-
Emergency Contraceptive Pills
... at a CAGR of 2.4% over the analysis period 2024-2030. Combination Pills, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$484.2 Million by the end of ... Read More
-
Fertility Services
... CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor Fertility Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Endometrial Cancer Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$31.3 Billion by the end of the ... Read More
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Assisted Reproductive Technology Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
... rise of the assisted reproductive technology sector is mostly being driven by advancements in medical technology, rising infertility rates, delayed childbearing, increased awareness, shifting societal standards, and government assistance. The report Assisted Reproductive Technology Market ... Read More
-
Women's Health Therapeutics
... at a CAGR of 12.9% over the analysis period 2024-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$18.1 Billion by the end ... Read More
-
Endometriosis Drugs
... CAGR of 3.0% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Polycystic Ovary Syndrome (PCOS) Treatment
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Insulin-Sensitizing Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion ... Read More
-
Assisted Reproductive Technology
... at a CAGR of 4.9% over the analysis period 2024-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Pregnancy and Fertility Testing Products
... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 10.7% CAGR The Pregnancy and Fertility ... Read More
-
Breast Lesion Localization
... at a CAGR of 4.5% over the analysis period 2024-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of ... Read More
-
In-Vitro Fertilization
... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas Therapeutics & Diagnostics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and ... Read More
-
In Vitro Fertilization Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
... improvements in reproductive technologies, increased awareness, postponed pregnancies, government assistance, expanding healthcare infrastructure, and growing desire for fertility preservation are some of the major factors propelling the IVF industry. The report In Vitro Fertilization Market ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Breast Reconstruction
... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$629.5 Million by the end of the analysis ... Read More
-
Breast Biopsy Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$983.4 Million by the end ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by ... Read More
-
Global Pregnancy Skincare Products Competitive Landscape Professional Research Report 2025
... dryness, acne, pigmentation issues (like melasma or ＂pregnancy mask＂), and stretch marks. Pregnancy-safe skincare products are free from ingredients that are known to be potentially harmful to pregnant individuals or their developing babies, such as ... Read More
-
Fertility Clinics in Australia - Industry Market Research Report
... industry includes numerous treatment options, the most popular being in-vitro fertilisation (IVF) cycles. Several factors have driven demand for fertility treatments and procedures in recent years, particularly from women who are having children later in ... Read More
Research Assistance
